Literature DB >> 31734188

Interaction of Resistin and Systolic Blood Pressure in Psoriasis Severity.

Divya Seth1, Alexa N Ehlert2, Jackelyn B Golden3, Giovanni Damiani4, Thomas S McCormick4, Mark J Cameron3, Kevin D Cooper5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31734188      PMCID： PMC7225032          DOI： 10.1016/j.jid.2019.07.727

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  18 in total

1.  Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis.

Authors:  Hidetoshi Takahashi; Hitomi Tsuji; Masaru Honma; Akemi Ishida-Yamamoto; Hajime Iizuka
Journal:  Arch Dermatol Res       Date:  2013-01-05       Impact factor: 3.017

2.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

Review 3.  The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies.

Authors:  April W Armstrong; Caitlin T Harskamp; Ehrin J Armstrong
Journal:  J Hypertens       Date:  2013-03       Impact factor: 4.844

4.  Plasma resistin levels correlate with determinants of the metabolic syndrome.

Authors:  G D Norata; M Ongari; K Garlaschelli; S Raselli; L Grigore; A L Catapano
Journal:  Eur J Endocrinol       Date:  2007-02       Impact factor: 6.664

5.  Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation.

Authors:  A Johnston; S Arnadottir; J E Gudjonsson; A Aphale; A A Sigmarsdottir; S I Gunnarsson; J T Steinsson; J T Elder; H Valdimarsson
Journal:  Br J Dermatol       Date:  2008-06-28       Impact factor: 9.302

6.  Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in skin lesions.

Authors:  Lauren Y Cao; David C Soler; Sarah M Debanne; Ivan Grozdev; Myriam E Rodriguez; Rivka L Feig; Teresa L Carman; Robert C Gilkeson; Carl E Orringer; Elizabeth F Kern; Thomas S McCormick; Kevin D Cooper; Neil J Korman
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

7.  Testing for qualitative interactions between treatment effects and patient subsets.

Authors:  M Gail; R Simon
Journal:  Biometrics       Date:  1985-06       Impact factor: 2.571

8.  Adiponectin and resistin plasma levels in healthy individuals with prehypertension.

Authors:  Dimitrios P Papadopoulos; Thomas K Makris; Panagiota G Krespi; Maria Poulakou; Georgios Stavroulakis; Antonios N Hatzizacharias; Despina Perrea; Vasilios V Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-12       Impact factor: 3.738

9.  Increased serum resistin levels correlate with psoriasis: a meta-analysis.

Authors:  Huiyun Huang; Erdong Shen; Shiqing Tang; Xingyou Tan; Xiuli Guo; Qiang Wang; Hongwei Ding
Journal:  Lipids Health Dis       Date:  2015-05-16       Impact factor: 3.876

Review 10.  Association between serum resistin concentration and hypertension: A systematic review and meta-analysis.

Authors:  Yuxiang Zhang; Yixing Li; Lin Yu; Lei Zhou
Journal:  Oncotarget       Date:  2017-06-20
View more
  5 in total

1.  The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study.

Authors:  Vikram K Mahajan; Narvir S Chauhan; Baldev S Rana; Karaninder S Mehta; Sheenam Hooda; Pushpinder S Chauhan; Amisha Kukreja
Journal:  J Clin Exp Hepatol       Date:  2021-12-03

2.  Serum Intestinal Metabolites are Raised in Patients with Psoriasis and Metabolic Syndrome.

Authors:  Liyun Sun; Xinwei Guo; Yeping Qin; Ping Li; Chunxia Yu; Xuesong Gao; Xinran Xie; Xuying Xu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-05-13

3.  Cyclodextrin-Modified CeO2 Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis.

Authors:  Lingyun Wu; Guoyan Liu; Wenyu Wang; Ruobing Liu; Lingyan Liao; Ni Cheng; Wentong Li; Weifen Zhang; Dejun Ding
Journal:  Int J Nanomedicine       Date:  2020-04-15

4.  Chemical profiling and anti-psoriatic activity of marine sponge (Dysidea avara) in induced imiquimod-psoriasis-skin model.

Authors:  Mostafa Khaledi; Behzad Sharif Makhmal Zadeh; Annahita Rezaie; Melika Nazemi; Mehdi Safdarian; Mohammad Bagher Nabavi
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

Review 5.  Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy.

Authors:  Anna A Brożyna; Radomir M Slominski; Bogusław Nedoszytko; Michal A Zmijewski; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.